Activated Mouse Notch1 Transactivates Epstein-Barr Virus Nuclear Antigen 2-Regulated Viral Promoters

ABSTRACT Epstein-Barr virus nuclear antigen 2 (EBNA2) is essential for B-cell immortalization by EBV, most probably by its ability to transactivate a number of cellular and viral genes. EBNA2-responsive elements (EBNA2REs) have been identified in several EBNA2-regulated viral promoters, each of them carrying at least one RBP-Jκ recognition site. RBP-Jκ recruits EBNA2 to the EBNA2RE and, once complexed to EBNA2, is converted from a repressor into an activator. An activated form of the cellular receptor Notch also interacts with RBP-Jκ, providing a link between EBNA2 and Notch signalling. To determine whether activated Notch is able to transactivate EBNA2-responsive viral promoters, we performed cotransfection experiments with activated mouse Notch1 (mNotch1-IC) and luciferase constructs of the BamHI C, LMP1, and LMP2A promoters. We present here evidence that mNotch1-IC transactivates viral promoters known to be regulated by EBNA2. As shown for EBNA2, mutations or deletions of the RBP-Jκ sites diminish or eliminate mNotch1-IC-mediated transactivation of the promoters, pointing to an essential role for Notch–RBP-Jκ interaction. In addition to RBP-Jκ, other cellular factors may bind within the EBNA2REs of viral promoters. While some factors appear to play an important role in both EBNA2- and mNotch1-IC-mediated transactivation, others are only important for the activity of either EBNA2 or mNotch1-IC. We could observe specific mNotch1-IC-responsive regions, thereby throwing more light upon which cofactors interact with EBNA2 and mNotch1-IC, thus enabling them to become functionally transactivators in vivo.

[1]  S. Minoguchi,et al.  Functional Replacement of the Intracellular Region of the Notch1 Receptor by Epstein-Barr Virus Nuclear Antigen 2 , 1998, Journal of Virology.

[2]  Raphael Kopan,et al.  Notch-1 signalling requires ligand-induced proteolytic release of intracellular domain , 1998, Nature.

[3]  G. Struhl,et al.  Nuclear Access and Action of Notch In Vivo , 1998, Cell.

[4]  A. Bigas,et al.  Notch1 and Notch2 Inhibit Myeloid Differentiation in Response to Different Cytokines , 1998, Molecular and Cellular Biology.

[5]  E. Fuentes-Pananá,et al.  Characterization of the CBF2 Binding Site within the Epstein-Barr Virus Latency C Promoter and Its Role in Modulating EBNA2-Mediated Transactivation , 1998, Journal of Virology.

[6]  B. Trask,et al.  The human homolog of rat Jagged1 expressed by marrow stroma inhibits differentiation of 32D cells through interaction with Notch1. , 1998, Immunity.

[7]  L. Strobl,et al.  Both Epstein-Barr viral nuclear antigen 2 (EBNA2) and activated Notch1 transactivate genes by interacting with the cellular protein RBP-J kappa. , 1997, Immunobiology.

[8]  S. Minoguchi,et al.  RBP-L, a transcription factor related to RBP-Jkappa , 1997, Molecular and cellular biology.

[9]  B. Fowlkes,et al.  Notch activity influences the alphabeta versus gammadelta T cell lineage decision. , 1997, Cell.

[10]  B. Fowlkes,et al.  Notch Activity Influences the αβ versus γδ T Cell Lineage Decision , 1997, Cell.

[11]  I. Bernstein,et al.  Inhibition of granulocytic differentiation by mNotch1. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[12]  J. Rohn,et al.  Transduction of Notch2 in feline leukemia virus-induced thymic lymphoma , 1996, Journal of virology.

[13]  G. Weinmaster,et al.  An Activated Form of Notch Influences the Choice between CD4 and CD8 T Cell Lineages , 1996, Cell.

[14]  L. Girard,et al.  Frequent provirus insertional mutagenesis of Notch1 in thymomas of MMTVD/myc transgenic mice suggests a collaboration of c-myc and Notch1 for oncogenesis. , 1996, Genes & development.

[15]  S E Lux,et al.  Constitutively active human Notch1 binds to the transcription factor CBF1 and stimulates transcription through a promoter containing a CBF1-responsive element. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[16]  J. Sklar,et al.  Exclusive development of T cell neoplasms in mice transplanted with bone marrow expressing activated Notch alleles , 1996, The Journal of experimental medicine.

[17]  J. Hsieh,et al.  Truncated mammalian Notch1 activates CBF1/RBPJk-repressed genes by a mechanism resembling that of Epstein-Barr virus EBNA2 , 1996, Molecular and cellular biology.

[18]  H. Weintraub,et al.  Signal transduction by activated mNotch: importance of proteolytic processing and its regulation by the extracellular domain. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[19]  M. Pawlita,et al.  Epstein-Barr virus nuclear antigen 2 (EBNA2)-oestrogen receptor fusion proteins complement the EBNA2-deficient Epstein-Barr virus strain P3HR1 in transformation of primary B cells but suppress growth of human B cell lymphoma lines. , 1996, The Journal of general virology.

[20]  S. Minoguchi,et al.  Physical interaction between a novel domain of the receptor Notch and the transcription factor RBP-Jκ/Su(H) , 1995, Current Biology.

[21]  K. Gupta,et al.  A highly efficient procedure for site-specific mutagenesis of full-length plasmids using Vent DNA polymerase. , 1995, Genome research.

[22]  F. Schweisguth,et al.  The neurogenic suppressor of hairless DNA-binding protein mediates the transcriptional activation of the enhancer of split complex genes triggered by Notch signaling. , 1995, Genes & development.

[23]  J. Posakony,et al.  Suppressor of hairless directly activates transcription of enhancer of split complex genes in response to Notch receptor activity. , 1995, Genes & development.

[24]  Christel Brou,et al.  Signalling downstream of activated mammalian Notch , 1995, Nature.

[25]  David Ish-Horowicz,et al.  Primary neurogenesis in Xenopus embryos regulated by a homologue of the Drosophila neurogenic gene Delta , 1995, Nature.

[26]  J. Hsieh,et al.  Masking of the CBF1/RBPJ kappa transcriptional repression domain by Epstein-Barr virus EBNA2. , 1995, Science.

[27]  E. Kremmer,et al.  Rat monoclonal antibodies differentiating between the Epstein-Barr virus nuclear antigens 2A (EBNA2A) and 2B (EBNA2B). , 1995, Virology.

[28]  D. Thorley-Lawson,et al.  A novel form of Epstein-Barr virus latency in normal B cells in vivo , 1995, Cell.

[29]  E. Kieff,et al.  Epstein-Barr virus nuclear protein 2 transactivation of the latent membrane protein 1 promoter is mediated by J kappa and PU.1 , 1995, Journal of virology.

[30]  E. Kremmer,et al.  B‐cell proliferation and induction of early G1‐regulating proteins by Epstein‐Barr virus mutants conditional for EBNA2. , 1995, The EMBO journal.

[31]  Kenji Matsuno,et al.  Notch signaling. , 1995, Science.

[32]  L. Waltzer,et al.  RBP-J kappa repression activity is mediated by a co-repressor and antagonized by the Epstein-Barr virus transcription factor EBNA2. , 1995, Nucleic acids research.

[33]  L. Waltzer,et al.  The human J kappa recombination signal sequence binding protein (RBP‐J kappa) targets the Epstein‐Barr virus EBNA2 protein to its DNA responsive elements. , 1994, The EMBO journal.

[34]  F. Moreau-Gachelin,et al.  The Spi‐1/PU.1 and Spi‐B ets family transcription factors and the recombination signal binding protein RBP‐J kappa interact with an Epstein‐Barr virus nuclear antigen 2 responsive cis‐element. , 1994, The EMBO journal.

[35]  L. Strobl,et al.  Crucial sequences within the Epstein-Barr virus TP1 promoter for EBNA2-mediated transactivation and interaction of EBNA2 with its responsive element , 1994, Journal of virology.

[36]  U. Zimber-Strobl,et al.  Identification and characterization of an Epstein-Barr virus nuclear antigen 2-responsive cis element in the bidirectional promoter region of latent membrane protein and terminal protein 2 genes , 1994, Journal of virology.

[37]  M. Fortini,et al.  The suppressor of hairless protein participates in notch receptor signaling , 1994, Cell.

[38]  T. Honjo,et al.  Epstein‐Barr virus nuclear antigen 2 exerts its transactivating function through interaction with recombination signal binding protein RBP‐J kappa, the homologue of Drosophila Suppressor of Hairless. , 1994, The EMBO journal.

[39]  Raphael Kopan,et al.  An activated Notch suppresses neurogenesis and myogenesis but not gliogenesis in mammalian cells. , 1994, Development.

[40]  H. Weintraub,et al.  The intracellular domain of mouse Notch: a constitutively activated repressor of myogenesis directed at the basic helix-loop-helix region of MyoD. , 1994, Development.

[41]  E. Kieff,et al.  The Epstein-Barr virus nuclear antigen 2 transactivator is directed to response elements by the J kappa recombination signal binding protein. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[42]  P. Ling,et al.  Mediation of Epstein-Barr virus EBNA2 transactivation by recombination signal-binding protein J kappa. , 1994, Science.

[43]  T. Honjo,et al.  The recombination signal sequence-binding protein RBP-2N functions as a transcriptional repressor , 1994, Molecular and cellular biology.

[44]  I. Bernstein,et al.  A human homologue of the Drosophila developmental gene, Notch, is expressed in CD34+ hematopoietic precursors. , 1994, Blood.

[45]  G. Klein,et al.  Cell phenotype-dependent control of Epstein-Barr virus latent membrane protein 1 gene regulatory sequences. , 1993, Virology.

[46]  D. Housman,et al.  Mouse beta-globin DNA-binding protein B1 is identical to a proto-oncogene, the transcription factor Spi-1/PU.1, and is restricted in expression to hematopoietic cells and the testis , 1993, Molecular and cellular biology.

[47]  E. Kremmer,et al.  The Epstein‐Barr virus nuclear antigen 2 interacts with an EBNA2 responsive cis‐element of the terminal protein 1 gene promoter. , 1993, The EMBO journal.

[48]  D. Gutsch,et al.  Identification of critical cis elements involved in mediating Epstein-Barr virus nuclear antigen 2-dependent activity of an enhancer located upstream of the viral BamHI C promoter , 1992, Journal of virology.

[49]  E. Kieff,et al.  Delineation of the cis-acting element mediating EBNA-2 transactivation of latent infection membrane protein expression , 1991, Journal of virology.

[50]  A. Polack,et al.  The intron enhancer of the immunoglobulin kappa gene activates c-myc but does not induce the Burkitt-specific promoter shift. , 1991, Oncogene.

[51]  J. Sklar,et al.  TAN-1, the human homolog of the Drosophila Notch gene, is broken by chromosomal translocations in T lymphoblastic neoplasms , 1991, Cell.

[52]  E. Kieff,et al.  Epstein-Barr virus nuclear protein 2 transactivates a cis-acting CD23 DNA element , 1991, Journal of virology.

[53]  E. Kieff,et al.  Induction of bcl-2 expression by epstein-barr virus latent membrane protein 1 protects infected B cells from programmed cell death , 1991, Cell.

[54]  D. Gutsch,et al.  EBNA-2 transactivates a lymphoid-specific enhancer in the BamHI C promoter of Epstein-Barr virus , 1991, Journal of virology.

[55]  G. Lenoir,et al.  Epstein-Barr virus nuclear antigen 2 activates transcription of the terminal protein gene , 1991, Journal of virology.

[56]  R. Fåhraeus,et al.  Epstein-Barr virus-encoded nuclear antigen 2 activates the viral latent membrane protein promoter by modulating the activity of a negative regulatory element. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[57]  E. Kieff,et al.  Epstein-Barr virus nuclear antigen 2 transactivates latent membrane protein LMP1 , 1990, Journal of virology.

[58]  J. Knutson The level of c-fgr RNA is increased by EBNA-2, an Epstein-Barr virus gene required for B-cell immortalization , 1990, Journal of virology.

[59]  M. Rowe,et al.  Epstein-Barr virus nuclear antigen 2 induces expression of the virus-encoded latent membrane protein , 1990, Journal of virology.

[60]  J. Banchereau,et al.  Stable transfection of Epstein-Barr virus (EBV) nuclear antigen 2 in lymphoma cells containing the EBV P3HR1 genome induces expression of B-cell activation molecules CD21 and CD23 , 1990, Journal of virology.

[61]  J. Strominger,et al.  Promoter switching in Epstein-Barr virus during the initial stages of infection of B lymphocytes. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[62]  T. Honjo,et al.  A protein binding to the Jk recombination sequence of immunoglobulin genes contains a sequence related to the integrase motif , 1989, Nature.

[63]  E. Kieff,et al.  Epstein-Barr virus nuclear protein 2 is a key determinant of lymphocyte transformation. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[64]  T. Honjo,et al.  Purification and characterization of a protein that binds to the recombination signal sequence of the immunoglobulin Jx segment , 1989 .

[65]  W. Hammerschmidt,et al.  Genetic analysis of immortalizing functions of Epstein–Barr virus in human B lymphocytes , 1989, Nature.

[66]  T. Honjo,et al.  Purification and characterization of a protein that binds to the recombination signal sequence of the immunoglobulin J kappa segment. , 1989, Nucleic acids research.

[67]  J. Banchereau,et al.  Epstein-Barr virus (EBV) induces expression of B-cell activation markers on in vitro infection of EBV-negative B-lymphoma cells. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[68]  E. Kieff,et al.  Epstein-Barr virus nuclear antigen 2 specifically induces expression of the B-cell activation antigen CD23. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[69]  P. L. Deininger,et al.  DNA sequence and expression of the B95-8 Epstein—Barr virus genome , 1984, Nature.

[70]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[71]  R. Roeder,et al.  Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. , 1983, Nucleic acids research.

[72]  L. Heston,et al.  Non-immortalizing P3J-HR-1 Epstein-Barr virus: a deletion mutant of its transforming parent, Jijoye , 1982, Journal of virology.

[73]  W. Gilbert,et al.  Sequencing end-labeled DNA with base-specific chemical cleavages. , 1980, Methods in enzymology.

[74]  R. Pulvertaft A study of malignant tumours in Nigeria by short-term tissue culture , 1965, Journal of clinical pathology.

[75]  H. Kikutani,et al.  Epstein-Barr Virus Nuclear Protein 2 Transactivates a cis-Acting CD 23 DNA Element , 2022 .